The official blog of the Lung Institute.

Regenerative Medicine Solutions Expanding

30 Sep 2014
| Under Press | Posted by | 0 Comments

Sleep Apnea Institute and the Lung Institute Coming to Nashville

Tampa, FL (September 30, 2014) –Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new facility, the Sleep Apnea Institute, and the expansion of a new treatment center for the Lung Institute.

With the introduction of the Sleep Apnea Institute to Nashville, the hope is to bring awareness to those individuals that suffer from sleep apnea: both diagnosed and undiagnosed. With Nashville being a hub for medical technology, this was a prime location to expand the Lung Institute brand. After the current success of treating 400 patients at the clinic in Tampa, FL., the new expansion will bring stem cell treatments and innovative medicine to the Nashville area.

Jack Coleman, Jr, MD, will be the medical director of the Sleep Apnea Institute and the Lung Institute in Nashville. He holds a medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. In all, Dr. Coleman has been practicing medicine for over 40 years.

“I am very excited about these new facilities opening,” says Dr. Coleman. “The Sleep Apnea Institute and the Lung Institute are providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Nashville.”

About the Lung Institute

At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life.  Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.